Could This News Upset Vertex Pharmaceuticals' Prospects in the Billion-Dollar Pain Management Market?

Vertex Pharmaceuticals (VRTX -0.96%) is the global leader in cystic fibrosis (CF) treatment, and that specialty has helped it generate billions of dollars in earnings. But the company has also spent the past few years developing candidates outside of this treatment area, in an effort to become a well-diversified biotech player.In fact, Vertex's next product to market may be one that could treat one of the most common problems around -- pain -- and generate blockbuster revenue. The company aims to submit tha ...